1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11682
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKaralapillai, Dharshien
dc.contributor.authorKaufman, Melissaen
dc.contributor.authorWeinberg, Laurenceen
dc.date.accessioned2015-05-16T01:18:00Z
dc.date.available2015-05-16T01:18:00Z
dc.date.issued2013-03-01en
dc.identifier.citationCritical Care and Resuscitation; 15(1): 57-62en
dc.identifier.govdoc23432503en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/11682en
dc.description.abstractSugammadex is the first selective antagonist to reverse neuromuscular blockade induced by rocuronium and vecuronium. The mechanism by which sugammadex works is superior to current neuromuscular block reversal strategies in terms of speed, efficacy and side effects. There is little contemporary guidance on the use of sugammadex in intensive care medicine. This review covers the key pharmacological features, clinical uses and cost- effectiveness in the context of intensive care practice.en
dc.language.isoenen
dc.subject.otherHumansen
dc.subject.othergamma-Cyclodextrins.pharmacology.therapeutic useen
dc.titleSugammadex.en
dc.typeJournal Articleen
dc.identifier.journaltitleCritical Care and Resuscitationen
dc.identifier.affiliationAustin Health, Heidelberg, Victoria, Australia, Australiaen
dc.description.pages57-62en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/23432503en
dc.type.austinJournal Articleen
local.name.researcherKaralapillai, Dharshi
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptIntensive Care-
crisitem.author.deptAnaesthesia-
crisitem.author.deptAnaesthesia-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

24
checked on Sep 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.